Clinical role of anti-granulocyte MoAb versus radiolabeled white blood cells

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 54, Issue 6, 2010, Pages 599-616

  Ruf, J ^a   Oeser, C ^a   Amthauer, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Antibodies; Infection; Inflammation; Monoclonal

Indexed keywords

8 QUINOLINOL INDIUM IN 111; BESILESOMAB; BW 250 183; DRUG ANTIBODY; FANOLESOMAB TC 99M; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HUMAN ANTIMOUSE ANTIBODY; SULESOMAB TC 99M; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; APPENDICITIS; BACTERIAL ENDOCARDITIS; BONE SCINTISCANNING; CARDIOVASCULAR INFECTION; CELL LABELING; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG PROTEIN BINDING; DRUG SAFETY; ENTERITIS; HEART ABSCESS; HUMAN; IMMUNOGENICITY; IMMUNOSCINTIGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; INTESTINE INFECTION; ISOTOPE LABELING; JOINT SCINTISCANNING; KIDNEY INFECTION; LEUKOCYTE; MYOCARDITIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PERICARDITIS; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS INFECTION; PYREXIA IDIOPATHICA; RADIOACTIVITY; RECOMMENDED DRUG DOSE; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOFT TISSUE INFLAMMATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; GRANULOCYTES; HUMANS; INFECTION; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTES; MOLECULAR IMAGING; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 79953108831     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging 2006;50:167-92. (Pubitemid 44649658)
2. Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med 2009;39:11-26.
3. Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev 2010;110:3112-45.
4. Pineda C, Espinosa R, Pena A. Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy. Semin Plast Surg 2009;23:80-9.
5. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 2009;39:36-51.
6. Palestro CJ, Love C, Bhargava LL. Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging 2009;53:105-23.
7. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001;1:326-33. (Pubitemid 33586613)
8. Petruzzi N, Shanthly N, Thakur M. Recent trends in soft-tissue infection imaging. Semin Nucl Med 2009;39:115-23.
9. Peters AM, Saverymuttu SH, Bell RN, Lavender JP. Quantification of the distribution of the marginating granulocyte pool in man. Scand J Haematol 1985;34:111-20. (Pubitemid 15158489)
10. Spector WG, Lykke WJ, Willoubhgy PA. A quantitative study of leukocyte emigration in chronic inflammatory granulomata. J Pathol Bacteriol1967;93:101-7.
11. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66-78.
12. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30:1665-73. (Pubitemid 38017435)
13. Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 2006;47:587-94. (Pubitemid 46768459)
14. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 2006;47:1908-13. (Pubitemid 47544977)
15. Meignan M, Charpentier B, Wirquin E, Chavaudra J, Fries D, Galle P. Biological Effects and Irradiation Dose Induced in Human Lymphocytes in Vitro by an Intracellular Radionuclide:99m Tc. Radiat Res 1983;94:263-79. (Pubitemid 13056638)
16. Kelbaek H, Fogh J, Elmgreen J. In vitro labeling of human polymorphonuclear leukocytes with 99mTc. Eur J Nucl Med 1984;9:366-9.
17. Thakur ML, Lavender JP, Arnot RN, Silvester DJ, Segal AW. Indium-111-labeled autologous leukocytes in man. J Nucl Med 1977;18:1012-21.
18. International Commission on Radiological Protection. Annals of the ICRP, Publication 80, Radiation Dose to Patients from Radiopharmaceuticals, Ed. J Valentin, Elsevier Science, Oxford, UK; 1999. p. 67.
19. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol 2004;32:47-57. (Pubitemid 47618976)
20. Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:835-41.
21. de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 2010;37:842-8.
22. Locher JT, Seybold K, Andres RY, Schubiger PA, Mach JP, Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocyte antibodies. Nucl Med Commun 1986;7:659-70.
23. Tronco GG, Love C, Rini JN, Yu AK, Bhargava KK, Nichols KJ et al. Diagnosing prosthetic vascular graft infection with the antigranulocyte antibody 99mTc-fanolesomab. Nucl Med Commun. 2007;28:297-300. (Pubitemid 46679557)
24. Kerry JE, Marshall C, Griffiths PA, James MW, Scott BB. Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease. Nucl Med Commun 2005;26:245-51. (Pubitemid 40411048)
25. Joseph K, Höffken H, Dammann V. In-vivo-Markierung von Granulozyten mit Tc-99m-markierten monoklonalen Antikörpern: erste klinische Ergebnisse. Nuc Compact 1987;18:223-6.
26. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 1994;24:142-53.
27. Love C, Palestro CJ. 99mTc-fanolesomab Palatin Technologies. IDrugs 2003;6:1079-85.
28. Presta LG. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function. Adv Drug Deliv Rev. 2006;58:640-56. (Pubitemid 44262411)
29. Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med. 1994;35:1436-43. (Pubitemid 24280448)
30. EMEA/H/C/001045/European Public Assessment Report (EPAR).
31. EMEA/H/C/000111/ European Public Assessment Report (EPAR).
32. Eynon-Lewis NJ, Ferry D, Pearse MF. Themistocles Gluck: an unrecognised genius. BMJ 1992;305:1534-6.
33. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone J Surg 1998;80-A:910-22. (Pubitemid 28299712)
34. Masterson EL, Masri BA, Duncan CP. Treatment of infection at the site of total hip replacement. Instr Course Lect 1998;47:297-306.
35. Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect 1993;42:349-51.
36. Cofield RH. Uncemented total shoulder arthroplasty. A review. Clin Orthop Relat Res 1994;307:86-93.
37. Magnuson JE, Brown ML, Hauser MF, Berquist TH, Fitzgerald RH Jr, Klee GG. In-111 labeled leukocyte scintigraphy in suspected orthopedic prosthesis infection: Comparison with other imaging modalities. Radiology 1988;168:235-9.
38. Ashbrooke AB, Calvert PT. Bone scan appearances after uncemented hip replacement. J Royal Soc Med 1990;83:768-9.
39. Rosenthall L, Lepanto L, Raymond F. Radiophosphate uptake in asymptomatic knee arthroplasty. J Nucl Med 1987;28:1546-9.
40. Hofmann AA, Wyatt RWB, Daniels AU, Armstrong L, Alazraki N, Taylor A Jr. Bone scans after total knee arthroplasty in asymptomatic patients. Clin Orthop 1990;251:183-8. (Pubitemid 20088642)
41. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prostheses: Diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging Radiology 1991;179:645-8.
42. Love C, Tronco GG, Yu AK. Diagnosing lower extremity (LE) prosthetic joint infection: Bone, gallium & labeled leukocyte imaging. Presented at the 2008 SNM Meeting, New Orleans, LA, June 14-18, 2008
43. Glithero PR, Grigoris P, Harding LK, Hesslewood SR, McMinn DJ. White cell scans and infected joint replacements. Failure to detect chronic infection. J. Bone Joint Surg 1993;75:371-4.
44. Scher DM, Pak K, Lonner JH, Finkel JE, Zuckerman JD, Di Cesare PE. The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties. J Arthroplasty 2000;15:295-300. (Pubitemid 30208345)
45. Simonsen L, Buhl A, Oersnes T, Duus B. White blood cell scintigraphy for differentiation of infection and aseptic loosening: a retrospective study of 76 painful hip prostheses. Acta Orthop 2007;78:640-7. (Pubitemid 350034940)
46. Klett R, Kordelle J, Stahl U, Khalisi A, Puille M, Steiner D et al. Immunoscintigraphy of septic loosening of knee endoprosthesis: a retrospective evaluation of the antigranulocyte antibody BW 250/183. Eur J Nucl Med Mol Imaging 2003;30:1463-6. (Pubitemid 37356112)
47. Pakos EE, Fotopoulos AD, Stafilas KS, Gavriilidis I, Al BG, Tsiouris S et al. Use of (99m)Tc-sulesomab for the diagnosis of prosthesis infection after total joint arthroplasty. J Int Med Res 2007;35:474-81.
48. Gratz S, Behr TM, Reize P, Pfestroff A, Kampen WU, Hoffken H. (99m)Tc-Fab' fragments (sulesomab) for imaging septically loosened total knee arthroplasty. J Int Med Res 2009;37:54-67.
49. Rubello D, Rampin L, Banti E, Grassetto G, Massaro A, Cittadin S et al. Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance of delayed 20-24-h imaging and semiquantitative analysis. Nucl Med Commun 2008;29:994-8.
50. Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics 2006;26:859-70.
51. Love C, Marwin SE, Tomas MB, Krauss ES, Tronco GG, Bhargava KK et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 2004;45:1864-71.
52. Palestro CJ, Kim CK, Swyer AJ, Capozzi JD, Solomon RW, Goldsmith SJ. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med 1990;31:1950-5.
53. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging 2008;35:2122-32.
54. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633-44.
55. Guidelines of the German Society of Nuclear Medicine. Differentialindikation für verschiedene radioaktive Arzneimittel bei unterschiedlichen entzündlichen Erkrankungen [Internet] Available from http://www.nuklearmedizin.de/leistungen/leitlinien/html/dif-indik.php?navId=53 [cited 2010, Nov 30].
56. Palestro CJ, Torres MA. Radionuclide diagnosis of orthopedic infections. Semin Nucl Med 1997;27:334-45.
57. Concia E, Prandini N, Massari L, Ghisellini F, Consoli V, Menichetti F et al. Osteomyelitis: clinical update for practical guidelines. Nucl Med Commun 2006;27:645-60.
58. Rozzanigo U, Tagliani A, Vittorini E, Pacchioni R, Brivio LR, Caudana R. Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis. Radiol Med 2009;114:121-32.
59. Ivanćević V, Perka C, Hasart O, Sandrock D, Munz DL. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery. Eur J Nucl Med Mol Imaging 2002;29:547-51.
60. Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996;17:10-6.
61. Peters AM. Nuclear medicine imaging in infection and inflammation. J R Coll Physicians Lond 1998;32:512-9.
62. Guze BH, Webber MM, Hawkins RA, Sinha K. Indium-111 white blood cell scans: sensitivity, specificity, accuracy, and normal patterns of distribution. Clin Nucl Med 1990;15:8-10.
63. Raptopoulos V, Doherty PW, Goss TP, King MA, Johnson K, Gantz NM. Acute osteomyelitis: advantage of white cell scans in early detection. AJR Am J Roentgenol 1982;139:1077-82.
64. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 1992;158:9-18.
65. Reuland P, Winker KH, Heuchert T, Ruck P, Müller-Schauenburg W, Weller S et al. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med 1991;32:2209-14.
66. Becker W, Palestro CJ, Winship J, Feld T, Pinsky CM, Wolf F et al. Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan). Clin Orthop Relat Res 1996;329:263-72.
67. Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 2005;87:2464-71.
68. Palestro CJ, Love C, Miller TT. Infection and musculoskeletal conditions: Imaging of musculoskeletal infections. Best Pract Res Clin Rheumatol 2006;20:1197-218.
69. Tsukayama DT. Pathophysiology of posttraumatic osteomyelitis. Clin Orthop Relat Res 1999;360:22-9.
70. Palestro CJ, Kim CK, Swyer AJ, Vallabhajosula S, Goldsmith SJ. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med 1991;32:1861-5.
71. Gratz S, Braun HG, Behr TM, Meiler J, Herrmann A, Conrad M et al. Photopenia in chronic vertebral osteomyelitis with technetium-99m- antigranulocyte antibody (BW 250/183). J Nucl Med 1997;38:211-6.
72. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
73. Damen GM, Krieken JH, Hoppenreijs E, van Os E, Tolboom JJ, Warris A et al. Overlap, Common Features, and Essential Differences in Pediatric Granulomatous Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2010 [Epub ahead of print].
74. Annovazzi A, Bagni B, Burroni L, D'Alessandria C, Signore A. Nucl Med Commun 2005;26:657-64.
75. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64-79.
76. Arndt JW, van der Sluys Veer A, Blok D, Griffoen G, Verspaget HW, Lamers CB et al. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993;34:1052-7.
77. Aydin F, Dinçer D, Güngör F, Boz A, Akça S, Yildiz A et al. Technetium-99m hexamethyl propylene amine oxime-labeled leukocyte scintigraphy at three different times in active ulcerative colitis: comparison with colonoscopy and clinico-biochemical parameters in the assessment of disease extension and severity. Ann Nucl Med. 2008;22:371-7.
78. Stokkel MP, Reigman HE, Pauwels EK. Scintigraphic head-to-head comparison between 99mTc-WBCs and 99mTc-LeukoScan in the evaluation of inflammatory bowel disease: a pilot study. Eur J Nucl Med Mol Imaging 2002;29:251-4.
79. Li DJ, Middleton SJ, Wraight EP. 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease. Nucl Med Commun 1992;13:867-70.
80. Papós M, Nagy F, Láng J, Csernay L. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease. Eur J Nucl Med 1993;20:766-9.
81. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: Diagnostic and clinical relevance. Gut 1993;34:1364-9.
82. Arndt JW, Grootscholten MI, van Hogezand RA, Griffioen G, Lamers CB, Pauwels EK. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes. Dig Dis Sci 1997;42:387-93.
83. Caobelli F, Panarotto MB, Andreoli F, Ravelli A, De Agostini A, Giubbini R. Is (99m)Tc-HMPAO granulocyte scan an alternative to endoscopy in pediatric chronic inflammatory bowel disease (IBD)? Eur J Pediatr 2010 [Epub ahead of print]. 84. Ruf J, Griebenow B, Stiller B, Sarioglu N, Lange PE, Amthauer
84. Ruf J, Griebenow B, Stiller B, Sarioglu N, Lange PE, Amthauer H. Detection of infectious colitis by 18F-fluorodeoxyglucose-positron emission tomography in a child receiving intensive care after cardiac surgery. Pediatr Radiol. 2005;35:702-5.
85. Spier BJ, Perlman SB, Reichelderfer M. FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging 2009;53:64-71.
86. Däbritz J, Jasper N, Loeffler M, Weckesser M, Foell D. Non-invasive assessment of pediatric inflammatory bowel disease with 18F-fluorodeoxyglucose- positron emission tomography and computed tomography. Eur J Gastroenterol Hepatol 2010 [Epub ahead of print].
87. Löffler M, Weckesser M, Franzius C, Schober O, Zimmer KP. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease.Ann N Y Acad Sci 2006;1072:379-85.
88. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine 2007;86:26-38.
89. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med 2003;253:263-75.
90. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992;152:21-2.
91. Durack DT, Street AC. Fever of unknown origin - reexamined and redefined. Curr Clin Top Infect Dis 1991;11:35-51.
92. de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine 1997;76:401-14.
93. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007;48:35-45.
94. Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A, Mansi L. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis.Nucl Med Commun 2006;27:213-22.
95. Meller J, Becker W. Nuclear medicine diagnosis of patients with fever of unknown origin (FUO). Nuklearmedizin 2001;40:59-70.
96. Becker W, Dölkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med 1993;20:1078-83.
97. Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, Becker W. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med 1998;39:1248-53.
98. Bleeker-Rovers CP, van der Meer JW, Oyen WJ. Fever of unknown origin. Semin Nucl Med 2009;39:81-7.
99. Kjaer A, Lebech AM, Eigtved A, Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004;31:622-6.
100. Balink H, Collins J, Bruyn GA, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin.Clin Nucl Med 2009;34:862-8.
101. nd edition. Edinburgh: Churchill Livingstone; 1999. p. 159-63.
102. Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg 1993;17:87-95.
103. Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomo- graphic findings. J Vasc Surg 2005;42:919-25.
104. Mark AS, McCarthy SN, Moss AA. Detection of abdominal aortic graft infection: comparrison of CT and In-labelled white blood cell scans. Am J Roentgenol 1985;144:315-8.
105. Reilly DT, Grigg MJ, Cunningham DA, Thomas EJ, Mansfield AO. Vascular graft imaging: the role of indium scanning. Eur J Vasc Endovasc Surg 1989;3:393-97.
106. Krznaric E, Nevelsteen A, van Hoe L, de Roo M, Schiepers C, Verbruggen A et al. Diagnostic value of 99Tcm-d,l-HMPAO-labelled leukocyte scintigraphy in the detection of vascular graft infections. Nucl Med Commun 1994;15:953-60.
107. Hobbs SD, Kumar S, Gilling-Smith GL. Epidemiology and diagnosis of endograft infection. J Cardiovasc Surg (Torino) 2010;51:5-14.
108. LaMuraglia GM, Fischman AJ, Strauss HW, Keech F, Wilkinson R, Callahan RJ et al. Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection. J Vasc Surg 1989;10:20-7.
109. Palestro CJ, Weiland FL, Seabold JE, Valdivia S, Tomas MB, Moyer BR et al. Localizing infection with a technetium-99m-labeled peptide: initial results. Nucl Med Commun 2001;22:695-701.
110. Venz S, Cordes M, Hepp W. [(123 I)-anti-NCA95 antibodies in diagnosis of bacterial wound infections after prosthetic vascular replacement. Comparison with computerized tomography]. Vasa 1994;23:138-44.
111. rd edition. Edinburgh: Churchill Livingstone; 2004. p. 981-91.
112. Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging 2009;53:35-40.
113. Bruggink JL, Glaudemans AW, Saleem BR, Meerwaldt R, Alkefaji H, Prins TR et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010;40:348-54.
114. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009;36:850-8.
115. Saam T, Rominger A, Wolpers S, Nikolaou K, Rist C, Greif M et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging 2010;37:1203-12.
116. Naber CK. Paul-Ehrlich-Gesellschaft für Chemotherapie; Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung; Deutschen Gesellschaft für Thorax-, Herz- und Gefässchirurgie; Deutschen Gesellschaft für Infektiologie; Deutschen Gesellschaft für Internistische Intensivmedizin und Notfallmedizin; Deutschen Gesellschaft für Hygiene und Mikrobiologie. S2 Guideline for diagnosis and therapy of infectious endocarditis. Z Kardiol 2004;93:1005-21.
117. Cerqueira MD, Jacobson AF. Indium-111 leukocyte scintigraphic detection of myocardial abscess formation in patients with endocarditis. J Nucl Med 1989;30:703-6.
118. Gratz S, Raddatz D, Hagenah G, Behr T, Béhé M, Becker W. 99mTC-labelled antigranulocyte monoclonal antibody FAB′ fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol 2000;75:75-84.
119. Morguet AJ, Munz DL, Kreuzer H, Emrich D. Scintigraphic detection of inflammatory heart disease. Eur J Nucl Med 1994;21:666-74.
120. Litzler PY, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med 2010;51:1044-8.
121. Calabrese F, van der Wal AC, Levi M. Infection and inflammation in the cardiovascular system. Cardiovasc Res 2003;60:1-4.
122. Kawai C, Matsumori A, Fujiwara H. Myocarditis and dilated cardiomyopathy. Ann Rev Med 1987;38:221-39.
123. Narula J, Khaw BA, Dec GW, Palacios IF, Newell JB, Southern JF et al. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol. 1996;3:371-81.
124. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-9.
125. Horowitz MS, Schultz CS, Stinson EB, Harrison DC, Popp RL. Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 1974;50:239-47.
126. Coupland DB, Terriff B, Fung AY, Sartori C. The 'hot halo' sign. Pyogenic pericarditis on In-111 leukocyte scintigraphy. Clin Nucl Med 1992;17:579-80.
127. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 2005;24:591-5.
128. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun 2006;27:757-64.
129. Vicente AG, Almoguera M, Alonso JC, Heffernan AJ, Gomez A, Contreras PI et al. Diagnosis of orthopedic infection in clinical practice using Tc-99m sulesomab (antigranulocyte monoclonal antibody fragment Fab′2). Clin Nucl Med 2004;29:781-5.